<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00436397</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000304713</org_study_id>
    <secondary_id>P30CA006927</secondary_id>
    <secondary_id>FCCC-02604</secondary_id>
    <nct_id>NCT00436397</nct_id>
  </id_info>
  <brief_title>A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer</brief_title>
  <official_title>Evaluation of the Radionics Body Localizer System and XPLAN/IMRT for Extra-Cranial Sites: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fox Chase Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Fox Chase Cancer Center</source>
  <brief_summary>
    <textblock>
      RATIONALE: A new radiation therapy planning system may help doctors plan better treatment for&#xD;
      patients with cancer.&#xD;
&#xD;
      PURPOSE: This clinical trial is studying a new radiation therapy planning system in patients&#xD;
      undergoing radiation therapy for extracranial cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Determine the ability of the Radionics Body System™ to immobilize and re-localize&#xD;
           patients receiving radiotherapy to extra-cranial sites of cancer.&#xD;
&#xD;
        -  Determine the accuracy of radiation dose calculations for extra-cranial sites of cancer&#xD;
           when using the XPLAN™-intensity modulated radiation therapy (XPLAN™/IMRT) integrated&#xD;
           software in this system.&#xD;
&#xD;
      OUTLINE: Patients receiving radiotherapy have a Body Localizer cast constructed and undergo a&#xD;
      CT scan while immobilized in the Body Localizer. Patients undergo another CT scan in the&#xD;
      treatment position using the standard alpha cradle. The XPLAN™-intensity modulated radiation&#xD;
      therapy (XPLAN™/IMRT)-generated treatment plan is compared to the standard treatment plan to&#xD;
      verify that the calculated dose is within 2-3 percent of the planned dose using standard&#xD;
      technique. Patients undergo sets of CT scans 3 additional times over the next few weeks for a&#xD;
      total of 8 CT scans Patients may undergo additional CT scans before and after radiotherapy&#xD;
      treatments for a maximum of 5 CT scans per week performed over the course of radiotherapy.&#xD;
&#xD;
      PROJECTED ACCRUAL: Approximately 60 patients will be accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">August 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Unspecified Adult Solid Tumor, Protocol Specific</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Cancer for which a course of radiotherapy to an extra-cranial site is required&#xD;
&#xD;
               -  Head and neck sites excluded&#xD;
&#xD;
          -  Initial treatment field (or cone down field) must be no greater than 12 X 10 cm&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Performance status&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Cardiovascular&#xD;
&#xD;
          -  No right heart insufficiency&#xD;
&#xD;
        Other&#xD;
&#xD;
          -  Not pregnant or nursing&#xD;
&#xD;
          -  Fertile patients must use effective contraception&#xD;
&#xD;
          -  Weight must not exceed 150 kilograms (330 pounds)&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
&#xD;
        Surgery&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Seigenberg, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fox Chase Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fox Chase Cancer Center - Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111-2497</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <study_first_submitted>February 15, 2007</study_first_submitted>
  <study_first_submitted_qc>February 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2007</study_first_posted>
  <last_update_submitted>February 11, 2010</last_update_submitted>
  <last_update_submitted_qc>February 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2010</last_update_posted>
  <keyword>unspecified adult solid tumor, protocol specific</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

